Bluestar Adisseo (600299.SH) announced the 2024 semi-annual performance forecast, and the company expects the net income attributable to shareholders of the listed company for the reporting period to be between 0.55 billion yuan and 0.65 billion yuan, a year-on-year increase of 1546.71% to 1846.11%. The net income attributable to shareholders of the listed company after deducting non-recurring profits and losses is expected to be between 0.65 billion yuan and 0.75 billion yuan, a year-on-year increase of 6009.02% to 6948.87%.
Zhicheng Financial APP news, Bluestar Adisseo (600299.SH) announced the 2024 semi-annual performance forecast, and the company expects the net income attributable to shareholders of the listed company for the reporting period to be between 0.55 billion yuan and 0.65 billion yuan, a year-on-year increase of 1546.71% to 1846.11%. The net income attributable to shareholders of the listed company after deducting non-recurring profits and losses is expected to be between 0.65 billion yuan and 0.75 billion yuan, a year-on-year increase of 6009.02% to 6948.87%.
The main reasons for the increase in performance this period are: 1. Strong growth in cystine business, mainly due to continuous penetration of liquid methionine and stable sales prices; 2. Specialty product business is still full of vitality, especially the rapid growth of monogastric animal products and aquatic products. Due to the low milk prices in the US dairy market, the rumination business has seen a slight rebound in the second quarter. 3. Raw material and energy costs have decreased.